Home > Qtrly Results > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]

BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Quarterly Results

Standalone Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Revenues ₹40 Cr ₹33 Cr ₹41 Cr ₹28 Cr ₹41 Cr ₹42 Cr ₹42 Cr ₹34 Cr
Expenses ₹37 Cr ₹32 Cr ₹39 Cr ₹31 Cr ₹37 Cr ₹36 Cr ₹35 Cr ₹31 Cr
Operating Income ₹4 Cr ₹1 Cr ₹3 Cr ₹-2 Cr ₹4 Cr ₹6 Cr ₹8 Cr ₹3 Cr
Other Income ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹2 Cr ₹0 Cr ₹2 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Depreciation ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹2 Cr ₹1 Cr
Profit Before Tax ₹3 Cr ₹-1 Cr ₹1 Cr ₹-3 Cr ₹2 Cr ₹6 Cr ₹6 Cr ₹3 Cr
Profit After Tax ₹3 Cr ₹-1 Cr ₹1 Cr ₹-3 Cr ₹2 Cr ₹6 Cr ₹5 Cr ₹3 Cr
EPS ₹1.11 ₹-0.31 ₹0.62 ₹-1.24 ₹1.05 ₹2.68 ₹2.27 ₹1.27
Industry Peers & Returns1W1M1Y
BAFNA PHARMACEUTICALS -5.8% 1.3% -3.1%
SUN PHARMACEUTICAL INDUSTRIES -3.7% -2.5% 31.9%
CIPLA -3.2% 0% 8.2%
DR REDDYS LABORATORIES -2.4% 7.3% 15.3%
ZYDUS LIFESCIENCES 2% 2.3% 37.9%
DIVIS LABORATORIES 2.3% 2.1% 46.9%
MANKIND PHARMA -7.1% 1.2% 20.5%
TORRENT PHARMACEUTICALS -2.1% -2.8% 37.8%
LUPIN -4.3% 3.8% 53.3%

BAFNA PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

21.14 %

Y-o-Y

-0.87 %

Quarters Revenues % Change
Sep2024 ₹40 Cr
21.14
Jun2024 ₹33 Cr
-19.60
Mar2024 ₹41 Cr
45.55
Dec2023 ₹28 Cr
-30.08
Sep2023 ₹41 Cr
-3.03
Jun2023 ₹42 Cr
-0.70
Mar2023 ₹42 Cr
23.46
Dec2022 ₹34 Cr -

BAFNA PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

213.13 %

Y-o-Y

-5.29 %

Quarters Operating Profit % Change
Sep2024 ₹4 Cr
213.13
Jun2024 ₹1 Cr
-58.07
Mar2024 ₹3 Cr
Positive
Dec2023 ₹-2 Cr
Negative
Sep2023 ₹4 Cr
-36.38
Jun2023 ₹6 Cr
-17.40
Mar2023 ₹8 Cr
150.49
Dec2022 ₹3 Cr -
Operating Margins
Q-o-Q

158.24 %

Y-o-Y

-4.47 %

Quarters Operating Margin% % Change
Sep2024 9.4%
158.24
Jun2024 3.64%
-47.85
Mar2024 6.98%
Positive
Dec2023 -7.3%
Negative
Sep2023 9.84%
-34.40
Jun2023 15%
-16.85
Mar2023 18.04%
102.92
Dec2022 8.89% -

BAFNA PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Positive

Y-o-Y

5.31 %

Quarters Profit After Tax % Change
Sep2024 ₹3 Cr
Positive
Jun2024 ₹-1 Cr
Negative
Mar2024 ₹1 Cr
Positive
Dec2023 ₹-3 Cr
Negative
Sep2023 ₹2 Cr
-60.88
Jun2023 ₹6 Cr
18.23
Mar2023 ₹5 Cr
79.33
Dec2022 ₹3 Cr -
PAT Margins
Q-o-Q

Positive

Y-o-Y

6.22 %

Quarters PAT Margin(%) % Change
Sep2024 6.49 %
Positive
Jun2024 -2.17 %
Negative
Mar2024 3.52 %
Positive
Dec2023 -10.35 %
Negative
Sep2023 6.11 %
-59.64
Jun2023 15.14 %
19.12
Mar2023 12.71 %
45.26
Dec2022 8.75 % -

BAFNA PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Positive

Y-o-Y

5.71 %

Quarters EPS % Change
Sep2024 ₹1.11
Positive
Jun2024 ₹-0.31
Negative
Mar2024 ₹0.62
Positive
Dec2023 ₹-1.24
Negative
Sep2023 ₹1.05
-60.82
Jun2023 ₹2.68
18.06
Mar2023 ₹2.27
78.74
Dec2022 ₹1.27 -

You may also like the below Video Courses